Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142019 |
| CAS No | NA |
| Mol.F. | C19H18N2O |
| Mol.Wt. | 290.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142020 |
| CAS No | NA |
| Mol.F. | C21H22N2O3 |
| Mol.Wt. | 350.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142021 |
| CAS No | NA |
| Mol.F. | C26H34N2O9 |
| Mol.Wt. | 518.56 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142022 |
| CAS No | NA |
| Mol.F. | C17H25IN2O5 |
| Mol.Wt. | 464.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142023 |
| CAS No | NA |
| Mol.F. | C17H22N2O3 |
| Mol.Wt. | 302.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142024 |
| CAS No | NA |
| Mol.F. | C17H26N2O3 |
| Mol.Wt. | 306.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142025 |
| CAS No | NA |
| Mol.F. | C10H12N6O5 |
| Mol.Wt. | 296.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142026 |
| CAS No | NA |
| Mol.F. | C19H18FN7O6 |
| Mol.Wt. | 459.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142027 |
| CAS No | NA |
| Mol.F. | C22H28N2O4 |
| Mol.Wt. | 384.14 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142028 |
| CAS No | NA |
| Mol.F. | C10H12N2O |
| Mol.Wt. | 176.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142029 |
| CAS No | NA |
| Mol.F. | C12H12N2O |
| Mol.Wt. | 200.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142030 |
| CAS No | NA |
| Mol.F. | C31H48N2O12 |
| Mol.Wt. | 640.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142031 |
| CAS No | NA |
| Mol.F. | C20H22N2O5 |
| Mol.Wt. | 370.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142032 |
| CAS No | NA |
| Mol.F. | C16H16N2O6 |
| Mol.Wt. | 332.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142033 |
| CAS No | NA |
| Mol.F. | C21H20N2O8 |
| Mol.Wt. | 428.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142034 |
| CAS No | NA |
| Mol.F. | C17H10N2O8 |
| Mol.Wt. | 370.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |